Derivative Assay:Article Title: Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS -Mutant Lung Adenocarcinoma
Article Snippet: Three KRAS mut (A549, H2030, and H23), four EGFR mut (H1975, PC-9, HCC4006, and H3255) lung adenocarcinoma cell lines, and three normal lung epithelial cells (HAE, BEAS-2B, and HPL1D) were used in this study: A549 cell line derived from adenocarcinomic human alveolar basal epithelial cells (American Type Culture Collection [ATCC] catalog number CCL-185); H2030 cell line derived from metastatic lymph node of stage III lung adenocarcinoma (CRL-5914; ATCC); H23 cell line derived from lung adenocarcinoma of epithelial origin (CRL-5800; ATCC); H1975 cell line derived from lung adenocarcinoma of epithelial origin (CRL-5908; ATCC); PC-9 cell line derived from undifferentiated type of lung adenocarcinoma (90071810; Sigma-Aldrich); HCC4006 cell line derived from metastatic pleural effusion of lung adenocarcinoma (CRL-2871; ATCC); H3255 cell line derived from metastatic pleural effusion of lung adenocarcinoma (ATCC, CRL-2882); 1HAEo, a post-crisis SV-40 T antigen transformed epithelial cell line (obtained from Dr. Dieter Gruenert, California Pacific Medical Center, University of California, San Francisco, San Francisco, CA, USA) ; BEAS-2B cell line expressing keratins and SV40 T antigen derived from normal human bronchial epithelium (CRL-9609; ATCC); and HPL1D cell line expressing SV40 T antigen derived from normal human small airway epithelium (originally generated by Takashi Takahashi from Nagoya University, Japan).
Transformation Assay:Article Title: Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS -Mutant Lung Adenocarcinoma
Article Snippet: Three KRAS mut (A549, H2030, and H23), four EGFR mut (H1975, PC-9, HCC4006, and H3255) lung adenocarcinoma cell lines, and three normal lung epithelial cells (HAE, BEAS-2B, and HPL1D) were used in this study: A549 cell line derived from adenocarcinomic human alveolar basal epithelial cells (American Type Culture Collection [ATCC] catalog number CCL-185); H2030 cell line derived from metastatic lymph node of stage III lung adenocarcinoma (CRL-5914; ATCC); H23 cell line derived from lung adenocarcinoma of epithelial origin (CRL-5800; ATCC); H1975 cell line derived from lung adenocarcinoma of epithelial origin (CRL-5908; ATCC); PC-9 cell line derived from undifferentiated type of lung adenocarcinoma (90071810; Sigma-Aldrich); HCC4006 cell line derived from metastatic pleural effusion of lung adenocarcinoma (CRL-2871; ATCC); H3255 cell line derived from metastatic pleural effusion of lung adenocarcinoma (ATCC, CRL-2882); 1HAEo, a post-crisis SV-40 T antigen transformed epithelial cell line (obtained from Dr. Dieter Gruenert, California Pacific Medical Center, University of California, San Francisco, San Francisco, CA, USA) ; BEAS-2B cell line expressing keratins and SV40 T antigen derived from normal human bronchial epithelium (CRL-9609; ATCC); and HPL1D cell line expressing SV40 T antigen derived from normal human small airway epithelium (originally generated by Takashi Takahashi from Nagoya University, Japan).
Expressing:Article Title: Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS -Mutant Lung Adenocarcinoma
Article Snippet: Three KRAS mut (A549, H2030, and H23), four EGFR mut (H1975, PC-9, HCC4006, and H3255) lung adenocarcinoma cell lines, and three normal lung epithelial cells (HAE, BEAS-2B, and HPL1D) were used in this study: A549 cell line derived from adenocarcinomic human alveolar basal epithelial cells (American Type Culture Collection [ATCC] catalog number CCL-185); H2030 cell line derived from metastatic lymph node of stage III lung adenocarcinoma (CRL-5914; ATCC); H23 cell line derived from lung adenocarcinoma of epithelial origin (CRL-5800; ATCC); H1975 cell line derived from lung adenocarcinoma of epithelial origin (CRL-5908; ATCC); PC-9 cell line derived from undifferentiated type of lung adenocarcinoma (90071810; Sigma-Aldrich); HCC4006 cell line derived from metastatic pleural effusion of lung adenocarcinoma (CRL-2871; ATCC); H3255 cell line derived from metastatic pleural effusion of lung adenocarcinoma (ATCC, CRL-2882); 1HAEo, a post-crisis SV-40 T antigen transformed epithelial cell line (obtained from Dr. Dieter Gruenert, California Pacific Medical Center, University of California, San Francisco, San Francisco, CA, USA) ; BEAS-2B cell line expressing keratins and SV40 T antigen derived from normal human bronchial epithelium (CRL-9609; ATCC); and HPL1D cell line expressing SV40 T antigen derived from normal human small airway epithelium (originally generated by Takashi Takahashi from Nagoya University, Japan).
Generated:Article Title: Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS -Mutant Lung Adenocarcinoma
Article Snippet: Three KRAS mut (A549, H2030, and H23), four EGFR mut (H1975, PC-9, HCC4006, and H3255) lung adenocarcinoma cell lines, and three normal lung epithelial cells (HAE, BEAS-2B, and HPL1D) were used in this study: A549 cell line derived from adenocarcinomic human alveolar basal epithelial cells (American Type Culture Collection [ATCC] catalog number CCL-185); H2030 cell line derived from metastatic lymph node of stage III lung adenocarcinoma (CRL-5914; ATCC); H23 cell line derived from lung adenocarcinoma of epithelial origin (CRL-5800; ATCC); H1975 cell line derived from lung adenocarcinoma of epithelial origin (CRL-5908; ATCC); PC-9 cell line derived from undifferentiated type of lung adenocarcinoma (90071810; Sigma-Aldrich); HCC4006 cell line derived from metastatic pleural effusion of lung adenocarcinoma (CRL-2871; ATCC); H3255 cell line derived from metastatic pleural effusion of lung adenocarcinoma (ATCC, CRL-2882); 1HAEo, a post-crisis SV-40 T antigen transformed epithelial cell line (obtained from Dr. Dieter Gruenert, California Pacific Medical Center, University of California, San Francisco, San Francisco, CA, USA) ; BEAS-2B cell line expressing keratins and SV40 T antigen derived from normal human bronchial epithelium (CRL-9609; ATCC); and HPL1D cell line expressing SV40 T antigen derived from normal human small airway epithelium (originally generated by Takashi Takahashi from Nagoya University, Japan).
|
ATCC is a verified supplier 
ATCC manufactures this product 